Reference summary — not medical advice or a personal risk estimate.
Tamoxifen (breast cancer therapy)
Selective oestrogen receptor modulator used against oestrogen-receptor-positive breast cancer.
Also known as: tamoxifen
IARC-classified factors documented in this product
- Exposure from · Source: IARC
Direct IARC Group 1 classification (endometrial cancer risk).
How to read this page
A factor appearing on this page means it has been documented in this product category — through EPA / FDA testing, IARC monographs, or regulatory recall records. Whether it presents a meaningful personal risk depends on the specific formulation, dose, and how you're exposed. Click any factor to read what science actually says about it, and where.